Skip to content
Personalized Phage Therapy Cures Teenage Patient of Life-Threatening Multidrug-Resistant Infection

Photo via Pexels

Discovery

Curated by Surfaced Editorial·Science·2 min read
Share:

A team at Great Ormond Street Hospital, in collaboration with the University of Pittsburgh, successfully treated a teenage cystic fibrosis patient, Isabelle Holdaway, with a personalized phage cocktail. Her disseminated *Mycobacterium abscessus* infection, resistant to 13 antibiotics, was completely cleared after compassionate use of a genetically modified phage blend. The phages were isolated from environmental samples, sequenced, and then modified to enhance their lytic activity against the specific bacterial strain. This case demonstrates the potential of highly individualized phage therapy to overcome infections deemed untreatable by conventional medicine. The groundbreaking success was reported in *Nature Medicine*.

Why It’s Fascinating

This case is profoundly significant as it provides compelling clinical evidence that phage therapy can save lives where antibiotics have failed, surprising many who had dismissed it as an outdated approach. It confirms the potential of a highly personalized approach to infectious disease, moving beyond broad-spectrum treatments. Within five years, we could see more rapid diagnostic tools for matching phages to specific bacterial strains and streamlined regulatory pathways for compassionate use. Think of it like a bespoke key perfectly fitting a lock that no master key could open. Patients suffering from chronic or acute multidrug-resistant infections are the primary beneficiaries. What ethical considerations arise when tailoring treatments so specifically for individual patients?

Enjoyed this? Get five picks like this every morning.

Free daily newsletter — zero spam, unsubscribe anytime.